Form 8-K - Current report:
SEC Accession No. 0001558370-24-000365
Filing Date
2024-01-18
Accepted
2024-01-18 16:38:03
Documents
13
Period of Report
2024-01-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20240111x8k.htm   iXBRL 8-K 38696
2 EX-3.1 rsls-20240111xex3d1.htm EX-3.1 113738
  Complete submission text file 0001558370-24-000365.txt   297538

Data Files

Seq Description Document Type Size
3 EX-101.SCH rsls-20240111.xsd EX-101.SCH 3105
4 EX-101.LAB rsls-20240111_lab.xml EX-101.LAB 15893
5 EX-101.PRE rsls-20240111_pre.xml EX-101.PRE 10249
7 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20240111x8k_htm.xml XML 4862
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 24542324
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)